Rankings
▼
Calendar
OCGN FY 2021 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$578M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$58M
Net Income
-$58M
EPS (Diluted)
$-0.30
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$49M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$106M
Total Liabilities
$10M
Stockholders' Equity
$96M
Cash & Equivalents
$95M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$43,000
-100.0%
Gross Profit
$0
-$6M
+100.0%
Operating Income
-$58M
-$21M
-172.6%
Net Income
-$58M
-$22M
-167.5%
← Q4 2020
All Quarters
Q1 2021 →